158 related articles for article (PubMed ID: 7035669)
1. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
Kovács G; Simonidesz V; Tömösközi I; Körmöczy P; Székely I; Papp-Behr A; Stadler I; Szekeres L; Papp G
J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
[No Abstract] [Full Text] [Related]
2. Syntheses and biological activities of some prostacyclin analogs.
Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
[No Abstract] [Full Text] [Related]
3. 11- and 15-deoxy-carboprostacyclins: hypothetic prostacyclin antagonists.
Mongelli N; Magni O; Gandolfi C; Grossoni M; Ceserani R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():281-5. PubMed ID: 6221538
[No Abstract] [Full Text] [Related]
4. The antiplatelet activity of immobilized prostacyclin.
Ebert CD; Lee ES; Kim SW
J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a highly potent analogue of prostacyclin, (-)-5-methyleneisocarbacyclin.
Amemiya S; Koyama K; Saito S; Kojima K
Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4403-5. PubMed ID: 3549013
[No Abstract] [Full Text] [Related]
6. Syntheses of 13-oxa- and 13-thiaprostacyclins: biologically potent analogs of prostacyclin.
Novák L; Aszódi J; Stadler I; Körmöczy P; Simonidesz V; Szántay C
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():275-80. PubMed ID: 6221537
[No Abstract] [Full Text] [Related]
7. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
[No Abstract] [Full Text] [Related]
8. 20-Methyl-prostacyclin analogs--a two stage screening procedure for biological properties.
Gandolfi CA; Gryglewski RJ
Pharmacol Res Commun; 1978 Nov; 10(10):885-96. PubMed ID: 366628
[No Abstract] [Full Text] [Related]
9. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
[TBL] [Abstract][Full Text] [Related]
10. [Prostacyclin in cardiovascular diseases].
Kishi Y; Numano F
Kokyu To Junkan; 1985 Jul; 33(7):865-9. PubMed ID: 3903901
[No Abstract] [Full Text] [Related]
11. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
12. A novel prostaglandin endoperoxide mimic, prostaglandin F2alpha acetal.
Portoghese PS; Larson DL; Abatjoglou AG
J Med Chem; 1977 Feb; 20(2):320-1. PubMed ID: 836508
[No Abstract] [Full Text] [Related]
13. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
[No Abstract] [Full Text] [Related]
14. 10,10-Difluoro-13-dehydroprostacyclin: a chemically and metabolically stabilized potent prostacyclin.
Fried J; Mitra DK; Nagarajan M; Mehrotra MM
J Med Chem; 1980 Mar; 23(3):234-7. PubMed ID: 6988588
[No Abstract] [Full Text] [Related]
15. Designing prostacyclin analogues.
Flohé L; Böhlke H; Frankus E; Kim SM; Lintz W; Loschen G; Michel G; Müller B; Schneider J; Seipp U
Arzneimittelforschung; 1983; 33(9):1240-8. PubMed ID: 6315026
[TBL] [Abstract][Full Text] [Related]
16. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
[No Abstract] [Full Text] [Related]
17. [Synthesis and antiaggregation activity of prostacyclin analogs. 1. Bicyclo [3.2.0] heptane analogs].
Lopp MI; Miuraus AI; Parve OV; Vialimiaé TK; Lopp AKh
Bioorg Khim; 1988 Feb; 14(2):222-31. PubMed ID: 3289544
[TBL] [Abstract][Full Text] [Related]
18. 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2).
Nicolaou KC; Barnette WE; Gasic GP; Magolda RL
J Am Chem Soc; 1977 Nov; 99(23):7736-8. PubMed ID: 334822
[No Abstract] [Full Text] [Related]
19. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
[TBL] [Abstract][Full Text] [Related]
20. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
